Merck (MRK) Current Deferred Tax Assets (2016 - 2023)
Merck (MRK) has disclosed Current Deferred Tax Assets for 15 consecutive years, with $6.6 billion as the latest value for Q2 2023.
- On a quarterly basis, Current Deferred Tax Assets fell 2.51% to $6.6 billion in Q2 2023 year-over-year; TTM through Jun 2023 was $6.6 billion, a 2.51% decrease, with the full-year FY2022 number at $7.2 billion, up 2.6% from a year prior.
- Current Deferred Tax Assets was $6.6 billion for Q2 2023 at Merck, down from $6.7 billion in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $7.2 billion in Q3 2022 to a low of $3.2 billion in Q1 2019.
- A 5-year average of $5.6 billion and a median of $6.0 billion in 2021 define the central range for Current Deferred Tax Assets.
- Peak YoY movement for Current Deferred Tax Assets: fell 21.38% in 2019, then soared 49.49% in 2021.
- Merck's Current Deferred Tax Assets stood at $4.3 billion in 2019, then rose by 9.28% to $4.7 billion in 2020, then skyrocketed by 49.49% to $7.0 billion in 2021, then rose by 2.6% to $7.2 billion in 2022, then dropped by 7.39% to $6.6 billion in 2023.
- Per Business Quant, the three most recent readings for MRK's Current Deferred Tax Assets are $6.6 billion (Q2 2023), $6.7 billion (Q1 2023), and $7.2 billion (Q4 2022).